Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 606 | 594 | 4,383 | 224 | 182 |
| Cost of Goods | 463 | 420 | 1,491 | 76 | 67 |
| Gross Profit | 143 | 174 | 2,892 | 148 | 115 |
| Operating Expenses | 2,367 | 2,121 | 2,623 | 1,754 | 1,571 |
| Operating Income | -1,761 | -1,527 | 760 | -1,530 | -1,389 |
| Interest Expense | 6 | 582 | 1,809 | 6 | 247 |
| Other Income | 519 | -131 | -238 | 215 | 87 |
| Pre-tax Income | -1,248 | -2,240 | -1,287 | -1,321 | -1,549 |
| Net Income Continuous | -1,248 | -2,240 | -1,287 | -1,321 | -1,549 |
| Net Income | $-1,248 | $-2,240 | $-1,287 | $-1,321 | $-1,549 |
| EPS Basic Total Ops | -0.27 | -0.48 | -0.28 | -0.29 | -0.36 |
| EPS Basic Continuous Ops | -0.27 | -0.48 | -0.17 | -0.29 | -0.36 |
| EPS Diluted Total Ops | -0.27 | -0.48 | -0.28 | -0.29 | -0.36 |
| EPS Diluted Continuous Ops | -0.27 | -0.48 | -0.17 | -0.29 | -0.36 |
| EBITDA(a) | $-1,630 | $-1,430 | $821 | $-1,404 | $-1,298 |